Home > Book Center>The Essence Comments on 200 Cases of Adverse Reactions Associated with Immune Checkpoint Inhibitors


This book mainly introduces that when immunologic agents act on the checkpoint proteins on cell surfaces, the immune system detects and destroys cancer cells so that a wide range of chemotherapy-refractory malignant tumors can be effectively treated. Because of the distinctive features of immunotherapy of cancer and the rapid progress made in the field, clinical guidance is needed on the use of these agents, including selection of appropriate patient, sequencing of treatment, reaction monitoring, adverse event management, and biomarker testing.

Copyright (C) 2014 Tsinghua University Press Ltd ICP No. 05029640 No. 11010802013248

Traffic:     Contact | lawyers | Link | Piracy Report